Clinical trial
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System Study
NCT01355406 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System Study
- Lead sponsor
- Cordis US Corp.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 16, 2011
- Completion date
- April 10, 2018
- Enrollment
- 257 (actual)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, pad, peripheral artery disease, peripheral vascular disease, vascular disease